Elie G. Dib: Huge shout-out to Dr. Brad Zebrack for spearheading this innovative research exemplifying the future of survivorship science!
Quoting Elie G. Dib, Associate Director of The Haematology Oncology training program at Saint Joseph Mercy Hospital, on LinkedIn:
“Join me in celebrating Dr. Brad Zebrack’s groundbreaking new study on health disparities in AYA cancer survivors! Dr. Zebrack’s study, “Social Genomic Mechanisms of Health Disparities among Adolescent and Young Adult Cancer Survivors,” will examine how social, environmental, and individual factors impact gene expression, survival, and quality of life in 18-39 year-old Hodgkin and non-Hodgkin lymphoma survivors.
This amazing study has the potential to transform our understanding of health equity and outcomes for AYA patients. By analyzing genomic mechanisms related to social adversity and resilience, this pioneering work can uncover the biological pathways driving health disparities and inform new interventions to improve equity and care.
I’m proud to share that EAQ211 study is now open at our cancer center, Michigan Cancer Research Consortium.We have an incredible opportunity to contribute to this groundbreaking research and create real impact for AYA cancer survivors. I encourage my fellow NCORP physicians to consider enrolling eligible patients. This is a chance to participate in transformative science on the biosocial determinants of cancer outcomes.
AYA lymphoma survivors – please ask your doctor about joining this study! Help propel scientific discovery and advance care for young adults affected by cancer. Huge shout-out to Brad Zebrack for spearheading this innovative research exemplifying the future of survivorship science!”
For the article click here.
Source: Elie G. Dib/LinkedIn.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023